Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Asston Pharmaceuticals Ltd (NSE: APL), ISIN INE0SJX01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
APL last traded at ₹147.65 (+4.64%), with a 52-week range of ₹60.00 to ₹153.40 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 39.48%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 10/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.